Homozygous Co-Deletion of Type I Interferons and CDKN2A Genes in Thoracic Cancers: Potential Consequences for Therapy - Archive ouverte HAL Access content directly
Journal Articles Frontiers in Oncology Year : 2021

Homozygous Co-Deletion of Type I Interferons and CDKN2A Genes in Thoracic Cancers: Potential Consequences for Therapy

(1, 2) , (1, 2) , (1, 2) , (1, 2, 3) , (1, 2, 3) , (1, 2)
1
2
3

Abstract

Homozygous deletion (HD) of the tumor suppressor gene CDKN2A is the most frequent genetic alteration in malignant pleural mesothelioma and is also frequent in non-small cell lung cancers. This HD is often accompanied by the HD of the type I interferons (IFN I) genes that are located closed to the CDKN2A gene on the p21.3 region of chromosome 9. IFN I genes encode sixteen cytokines (IFN-a, IFN-b…) that are implicated in cellular antiviral and antitumor defense and in the induction of the immune response. In this review, we discuss the potential influence of IFN I genes HD on thoracic cancers therapy and speak in favor of better taking these HD into account in patients monitoring.
Fichier principal
Vignette du fichier
Grard2021Eq04.pdf (826.22 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

inserm-03349933 , version 1 (21-09-2021)

Identifiers

Cite

Marion Grard, Camille Chatelain, Tiphaine Delaunay, Elvire Pons-Tostivint, Jaafar Bennouna, et al.. Homozygous Co-Deletion of Type I Interferons and CDKN2A Genes in Thoracic Cancers: Potential Consequences for Therapy. Frontiers in Oncology, 2021, 11, pp.695770. ⟨10.3389/fonc.2021.695770⟩. ⟨inserm-03349933⟩
22 View
17 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More